Xiu‐Ying Qin

1.5k citations
35 papers · 1.4k indexed · h-index 21
Topics
Metal complexes synthesis and properties (15 papers)Nanoplatforms for cancer theranostics (8 papers)Advanced biosensing and bioanalysis techniques (6 papers)
Partner nations
ChinaHong KongZambia

In The Last Decade

Xiu‐Ying Qin

35 papers receiving 1.3k citations

Peers

Xiu‐Ying Qin
Comparison fields: 5 of 91
  • Biomedical Engineering 526
  • Molecular Biology 417
  • Materials Chemistry 396
  • Oncology 339
  • Biomaterials 246
Replace Haoqiang Lai with:
Haoqiang Lai China
Yuanyuan You China
Tian‐Shu Kang Macao
Leung Chan China
Jinha Yu South Korea
Philippe Collery France
Yvonne E. Moussa Australia
Anthony J. Di Pasqua United States
Xiang Ma China
Jacinta O. Pinho Portugal
Xiu‐Ying Qin relative to Haoqiang Lai China Haoqiang Lai's profile →
Citations per field
00.5×1.5×
Haoqiang Lai · 1×
Citations per year

Countries citing papers authored by Xiu‐Ying Qin

Since Specialization
Citations

This map shows the geographic impact of Xiu‐Ying Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu‐Ying Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu‐Ying Qin more than expected).

Fields of papers citing papers by Xiu‐Ying Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu‐Ying Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu‐Ying Qin. The network helps show where Xiu‐Ying Qin may publish in the future.

Co-authorship network of co-authors of Xiu‐Ying Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiu‐Ying Qin. A scholar is included among the top collaborators of Xiu‐Ying Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiu‐Ying Qin. Xiu‐Ying Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 2
3 6
4 46
5 11
6 94
7 106
8 192
9 122
10 24
11 83
12 56
13 18
14 17
15 3
16 30
17 114
18 3
19 1
20 11

About Xiu‐Ying Qin

Xiu‐Ying Qin is a scholar working on Oncology, Applied Microbiology and Biotechnology and Inorganic Chemistry, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (15 papers), Nanoplatforms for cancer theranostics (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Biomaterials (246 citations), Oncology (339 citations) and Biomedical Engineering (526 citations). Xiu‐Ying Qin has collaborated with scholars based in China, Hong Kong and Zambia. Frequent co-authors include Jie Liu, Xufeng Zhu, Xu Chen, Yanhui Zhou, Youcong Gong, Licong Yang, Guanglong Yuan, Yanan Liu, Lanmei Chen and Qianqian Yu. Their work appears in journals such as ACS Nano, Biomaterials and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026